Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-28

FDA Approved: TICAGRELOR — Original Application (Radha Pharmaceuticals INC)

View source ↗

Summary

FDA approves Radha Pharmaceuticals INC's original ANDA for Ticagrelor, a generic antiplatelet medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TICAGRELOR (ticagrelor)

Snippet

ORIG AP for TICAGRELOR (TICAGRELOR)